Related Experiment Video
Updated: Aug 12, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Acute and Postacute Clinical Characteristics of Coronavirus Disease 2019 in Children in Japan
Tomohiro Katsuta1,2, Yuta Aizawa3, Kensuke Shoji4
1From the The Committee on Immunization and Infectious Diseases, Japan Pediatric Society, Japan.
Insights
Clinical features of coronavirus disease 2019 (COVID-19) in children evolved with variants of concern. A study in Japan found increased symptomatic cases and persistent symptoms, particularly during the Omicron variant period, highlighting the need for further research.
Area of Science:
- Pediatric infectious diseases
- Virology
- Public health
Background:
- Clinical features of COVID-19 in children have evolved due to variants of concern (VOC).
- Increased VOC infections raise concerns about persistent symptoms in pediatric COVID-19 cases.
- Understanding these changes is crucial for managing pediatric health during the pandemic.
Purpose of the Study:
- To analyze clinical manifestations of pediatric COVID-19 in Japan.
- To investigate persistent symptoms in children following COVID-19 infection.
- To assess the impact of different SARS-CoV-2 variants on pediatric cases.
Main Methods:
- Analysis of 5411 pediatric COVID-19 cases for clinical manifestations (Feb 2020-Apr 2022).
- Analysis of 1697 pediatric COVID-19 cases for persistent symptoms (Feb 2020-Nov 2021).
- Data collected via a dedicated database from the Japan Pediatric Society.
Main Results:
- Seizure incidence increased significantly during the Omicron variant period (13.4% in 1-4 years, 7.4% in 5-11 years).
- Persistent symptoms after 28 days were reported in 3.2% (55 cases) of pediatric patients.
- Symptomatic cases increased, especially during the Omicron predominant period.
Conclusions:
- Pediatric COVID-19 clinical features and symptom persistence vary with SARS-CoV-2 variants.
- A notable percentage of children experience prolonged symptoms or severe complications.
- Further longitudinal studies are necessary to monitor affected children.
Background:
The clinical features of coronavirus disease 2019 (COVID-19) in children have been changing because of the emergence and rapid spread of variants of concern (VOC). The increase in cases infected with VOC has brought concern with persistent symptoms after COVID-19 in children. This survey aimed to analyze the clinical manifestations and persistent symptoms of pediatric COVID-19 cases in Japan.
Methods:
We analyzed the clinical manifestations of pediatric COVID-19 cases reported between February 2020 and April 2022 in Japan, using a dedicated database updated voluntarily by the members of the Japan Pediatric Society. Using the same database, we also analyzed persistent symptoms after COVID-19 in children who were diagnosed between February 2020 and November 2021.
Results:
A total of 5411 and 1697 pediatric COVID-19 cases were included for analyzing clinical manifestations and persistent symptoms, respectively. During the Omicron variant predominant period, the percentage of patients with seizures increased to 13.4% and 7.4% in patient groups 1-4 and 5-11 years of age, respectively, compared with the pre-Delta (1.3%, 0.4%) or Delta period (3.1%, 0.0%). Persistent and present symptoms after 28 days of COVID-19 onset were reported in 55 (3.2%).
Conclusions:
Our survey showed that the rate of symptomatic pediatric COVID-19 cases increased gradually, especially during the Omicron variant predominant period, and a certain percentage of pediatric cases had persistent symptoms. Certain percentages of pediatric COVID-19 patients had severe complications or prolonged symptoms. Further studies are needed to follow such patients.
More Related Videos
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Kidney Injury III: Clinical Manifestations
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III